Amphera Announces a Positive Opinion of the European Medicines Agency on the Granting of Orphan Medicinal Product Designation for MesoPher in Pancreatic Cancer
Amphera B.V. announced that the European Medicines Agency Committee for Orphan Medicinal Products recommended the granting of orphan medicinal product designation for MesoPher in pancreatic cancer.